Caution, this is an AI generated summary based on literature. This may have errors, see here for more.
Please share your feedback with us.
MIR466: MIR466 is a miRNA that has been found to have five potential target genes that are differentially expressed in patients with age-related macular degeneration (AMD) compared to unaffected individuals [PMC5429617]. A previous study identified 17 new miRNAs, including MIR466, which belong to 11 miRNA families and can regulate 64 sorghum genes involved in various cellular processes [PMC5360763]. Among these processes are cell cycle regulation, metabolism, protein degradation, RNA processing, stress response, and transportation [PMC5360763]. MIR466 is also involved in the regulation of matrix metalloproteinase-9 (MMP9) expression and can downregulate its expression by binding to the 3' UTR region of MMP9 [PMC4568920]. Inhibition of MIR466 has been achieved using a specific inhibitor (AM18443) in endothelial cells (ECs), along with other miRNA inhibitors [PMC9307898]. Additionally, MIR466 has been shown to regulate expression of MMP9 in diabetic heart tissue and promote proliferation of ECs and formation of capillary-like structures [PMC8355361]. Overall, these findings highlight the importance of MIR466 in various biological processes and its potential as a therapeutic target for diseases such as AMD and diabetes-related heart damage.
Genome locations
Gene Ontology annotations
Ancestor Chart
Loading ontology ancestors...
Failed to load QuickGO Ancestor chart
Sequence
Sequence features are shown above as colored rectangles.
Zoom in and click to view details, or
Reset